Breast Cancer Screening Technology

AuraVu Medical Inc. is working on cutting-edge technology for safe and effective Breast Cancer Screening utilizing a proprietary Non-invasive Dynamic-Angio Thermographic Imaging Technology (NDTIT).

The technology is in the last phase of development and is scheduled to launch by the end of the first quarter of 2024.

Product Development Stage

Dynamic-Angio Thermographic Imaging Technology (NDTIT) is a technology for the screening and diagnosis of breast cancer. It records the temperature variations linked to the vascular changes in the breast due to angiogenesis. The presence, change, and growth of tumors and lesions in breast tissue change the vascular network in the breast. Consequently, by monitoring the vascular structure over time, NDTIT can effectively detect the change in breast tissue due to tumors and lesions.

NDTIT technology is low-cost compared to other imaging techniques and stands out by providing additional information to clarify the clinical picture and improving the quality of the diagnosis. In older thermography devices, doctors studied the color distribution in the image, while this new NDTIT device captures an image formulated for information about the local blood distribution.